$0.54
+0.02 (+4.77%)
Open$0.50
Previous Close$0.51
Day High$0.56
Day Low$0.49
52W High$4.85
52W Low$0.31
Volume—
Avg Volume1.16M
Market Cap1.99M
P/E Ratio—
EPS$-6.36
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+6,954.8% upside
Current
$0.54
$0.54
Target
$37.99
$37.99
$25.94
$37.99 avg
$62.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 29.48M | 25.89M | 257.5K |
| Net Income | -45,191,962 | -35,721,733 | -16,876 |
| Profit Margin | -153.3% | -145.6% | -6.6% |
| EBITDA | -37,890,710 | -31,614,416 | -21,131 |
| Free Cash Flow | — | — | -13,268 |
| Rev Growth | +13.9% | +13.9% | +2.0% |
| Debt/Equity | 0.08 | 0.08 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |